Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Background/Aims:Tenofovir disoproxil fumarate (TDF) exhibits similar antiviral efficacy against treatment-naïve and lamivudine (LAM)-resistant chronic hepatitis B (CHB). However, there are few clinical reports on the antiviral effects of TDF–LAM combination therapy compared to TDF monotherapy in pat...

Full description

Bibliographic Details
Main Authors: Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2016-03-01
Series:Clinical and Molecular Hepatology
Subjects:
Tenofovir
Lamivudine
Resistance
Chronic hepatitis B
Online Access:http://e-cmh.org/upload/pdf/cmh-22-1-152.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-22-1-152.pdf

Similar Items